| Obesity |
1 |
1 |
| Bariatric Surgery |
0 |
0.88 |
| Weight Loss |
0 |
0.53 |
| Coronary Artery Disease (CAD) |
0 |
0.5 |
| Coronary Artery Bypass Graft (CABG) |
0 |
0.41 |
| Surgery |
0 |
0.41 |
| Cardiac Surgery |
0 |
0.39 |
| Europe |
0 |
0.35 |
| Metabolism |
0 |
0.29 |
| Cardiovascular Risk Management |
0 |
0.28 |
| Weight Management |
0 |
0.27 |
| Heart |
0 |
0.23 |
| Intravenous |
0 |
0.23 |
| Hypertension |
0 |
0.21 |
| Artery |
0 |
0.18 |
| Cardiovascular disease |
0 |
0.18 |
| Hospital |
0 |
0.18 |
| Cardiac Rehabilitation |
0 |
0.12 |
| Dyslipidemia |
0 |
0.12 |
| Exercise |
0 |
0.12 |
| Stress |
0 |
0.12 |
| GLP-1 Receptor Agonist |
0 |
0.1 |
| Percutaneous Coronary Intervention |
0 |
0.1 |
| Myocardial Infarction (MI) |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Acute Myocardial Infarction (MI) |
0 |
0.08 |
| Blood |
0 |
0.06 |
| Canada |
0 |
0.06 |
| Chronic Disease |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Fellowship |
0 |
0.06 |
| Graft |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Hand |
0 |
0.06 |
| Infarction |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Massachusetts |
0 |
0.06 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.06 |
| Prognosis |
0 |
0.06 |
| Quality of Life |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Stigma |
0 |
0.06 |
| Type 2 Diabetes Mellitus |
0 |
0.03 |